The Comparision of Minimally-invasive and Open Pancreaticoduodenectomy for Pancreatic Cancer

Recruiting now · Not applicable

Conditions studied: Pancreatic Carcinoma, Surgery

In brief

Minimally invasive pancreaticoduodenectomy remains one of the most challenging abdominal procedures. Safety and feasibility remain controversial when comparing minimally-invasive with open pancreaticoduodenectomy, especially for malignant tumors.The aim of this study was to compare minimally invasive and open pancreatoduodenectomy for short-term outcomes and long-term follow-up in a randomized trial.

Key facts

Study ID

NCT03747588

Run by

Peking Union Medical College Hospital

People needed

100

Starts

2018-12-01

Expected to finish

2028-12-30

Last updated by the study team

2022-10-03

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age: >18yr, <75yr
• Patients with pancreatic cancer or non-pancreatic cancers (biliary duct cancer or ampullary cancer) who underwent pancreatoduodenectomy
• Preoperative imaging assessment is resectable or borderline resectable

You may not qualify if…

• Benign tumors of the head of pancreas
• Enhanced CT diagnosis revealed that the excess of SMV was more than 180 degrees, or distant metastasis.
• conversion to laparotomy because of intraoperative difficulty

Where it is running

• Chinese Academy of Medical Sciences & Peking Union Medical College Hospital — Beijing, Beijing Municipality, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.